Toll Free: 1800 103 1369 Email Us:customercare@canmoney.in

Markets

Market

MANKIND PHARMA LTD.

  • NSE CodeMANKINDEQ
  • BSE Code543904
  • ISININE634S01028
  • IndustryPharmaceuticals


Company Information

Management

Mr. Hitesh Kumar Jain

Co. Secretary & Compl. Officer

Mr. Ashutosh Dhawan

Global Chief Financial Officer

Mr. Arjun Juneja

Chief Operating Officer

Dr. Anil Kumar

Chief Scientific Officer

Incorporation Year

03/07/1991

Registered Address

Registered Office : 208, Okhla Industrial Estate, Phase-III,
New Delhi, Delhi - 110020
Tel: 011-47476600

Registrar Office

KFIN Technologies Pvt. Ltd.
Selenium Tower B, Plot No. 31-32,Gachibowli, Financial District, Nanakramguda,Serilingampally Man
Hyderabad,500032,Telangana
Tel: 040-67161500
Fax: 23420814

Email

investors@mankindpharma.com

Website

http://www.mankindpharma.com

Listing

BSE, NSE

Corporate News

Mankind Pharma - Analysts/Institutional Investor Meet...

27-Aug-2025|3:41PM

Mankind Pharma Limited has informed the Exchange about Schedule of meet

Mankind Pharma - Announcement under Regulation 30 (LO...

27-Aug-2025|3:38PM

Please find attached intimation of participation in Investor Conference

Mankind Pharma - ESOP/ESOS/ESPS

26-Aug-2025|2:36PM

Mankind Pharma Limited has informed the Exchange regarding Allotment of 297

Mankind Pharma - Announcement under Regulation 30 (LO...

26-Aug-2025|2:34PM

Allotment of 29,742 Equity Shares under Mankind Employee Stock Option Plan

More

Share Holding Pattern

Peer Comparison

Company NamePrice (₹)Market Cap(₹ Cr)
Aarey Drug60.16170.58
Aarti Drug469.554,285.58
Aarti Pharma841.357,626.10
Abbott India31,480.0066,892.80
Accent Micro284.15681.65
More

MF Holding

Scheme NameValue
(₹ Cr)		Holding (%)
SBI Large Cap..1045.601.97
HDFC Large Ca..471.911.24
Axis ELSS Tax..341.670.97
SBI Contra Fu..340.930.73
Invesco India..283.181.47
More

Board Meetings

DatePurpose
31/07/2025Quarterly Results &..
21/05/2025Audited Results
23/01/2025Quarterly Results
05/11/2024Quarterly Results
31/07/2024Quarterly Results
More